Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Type of study
Language
Publication year range
1.
Exp Parasitol ; 167: 50-60, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27174667

ABSTRACT

Human lymphatic filariasis (LF) is mainly caused by filarial parasite Wuchereria bancrofti and is the second leading cause of long term and permanent disability in tropical countries. To date, incapability to eliminate long lived adult parasites by current drugs remains the major challenge in the elimination of LF. Hence, in the current study, the efficacy of rhizome extracts of Curcuma zedoaria (a plant traditionally used in Sri Lanka in the management of LF) was evaluated as an effective filaricide in vitro. Sequential solvent extracts of C. zedoaria rhizomes were screened for in vitro antifilarial activity at 0.01-1 mg/mL concentrations by motility inhibition assay and 3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyl tetrazolium bromide (MTT) reduction assay using cattle parasite Setaria digitata as a model organism. Exposure of parasites to hexane and chloroform extracts of C. zedoaria caused a dose dependant reduction in motility and viability of microfilariae (IC50 = 72.42 µg/mL for hexane extract, 191.14 µg/mL for chloroform extract) and adult parasites (IC50 = 77.07 µg/mL for hexane extract, 259.87 µg/mL for chloroform extract). Both extracts were less toxic to human peripheral blood mononuclear cells when compared to filariae. A dose dependant increase in caspase 3/CED 3 and a decrease in total protein content, cyclooxygenase (COX) and protein tyrosine phosphatase (PTP) activities were observed in adult parasites treated with hexane or chloroform extract. A significant degree of chromatin condensation and apoptotic body formation were also observed in these worms by Hoechst 33342 and terminal deoxynucleotidyl transferase-mediated dUTP biotin nick end labeling (TUNEL) staining respectively. Dose dependant chromosomal DNA laddering was observed in treated adult worms but not in microfilariae in response to both extracts. Oxidative stress parameters such as reduction in reduced glutathione (GSH) levels and increase in glutathione s transferase (GST), superoxide dismutase (SOD) and catalase activities, increased reactive oxygen levels (ROS) and lipid peroxidation were also observed indicating that an apoptotic event is induced by reactive oxygen species.


Subject(s)
Curcuma/chemistry , Plant Extracts/pharmacology , Pyroptosis/drug effects , Reactive Oxygen Species/metabolism , Rhizome/chemistry , Setaria Nematode/drug effects , Animals , Caspase 3/metabolism , Cattle , DNA Fragmentation , Dose-Response Relationship, Drug , Female , Humans , In Situ Nick-End Labeling , Inhibitory Concentration 50 , Leukocytes, Mononuclear/drug effects , Peritoneal Cavity/parasitology , Plant Extracts/toxicity , Setaria Nematode/cytology , Setaria Nematode/metabolism
2.
Exp Parasitol ; 135(3): 599-605, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24090570

ABSTRACT

Murine infection with Taenia crassiceps cysticerci is used as an experimental model for human and animal cysticercosis. In this infection parasites can be found associated with an inflammatory infiltrate enriched with macrophages. Experimental evidence exists supporting a role for either NO-producing classically activated (CAMΦ) or arginase- and CD301-expressing alternatively activated macrophages (AAMΦ) in T. crassiceps resistance. In both cell types, arginine is utilized as an important mediator in macrophage effector functions. To investigate whether there is an association between arginine availability, susceptibility to T. crassiceps and other parameters such as fibrosis, BALB/c mice were infected intraperitoneally with cysticerci and treated daily with the arginase inhibitor nor-NOHA or supplemented with l-arginine and followed for eight weeks. The numbers and developmental stages of parasites were evaluated as well as the presence of CD301+ AAMΦ, arginase activity and collagen deposition in the peritoneal membrane. Treatment with the arginase inhibitor or supplementation with l-arginine did not change the parasitic load or profile of the infection. However, the arginase inhibitor significantly decreased the deposition of collagen. These results suggest that arginase activity does not interfere with parasite control during experimental infection with T. crassiceps, but it is important for fibrosis in cysticercosis.


Subject(s)
Arginase/metabolism , Cysticercosis/pathology , Peritoneal Fibrosis/enzymology , Animals , Arginase/antagonists & inhibitors , Arginine/analogs & derivatives , Arginine/metabolism , Arginine/pharmacology , Collagen/analysis , Cysticercosis/enzymology , Cysticercosis/immunology , Female , Macrophages, Peritoneal/enzymology , Mice , Mice, Inbred BALB C , Peritoneal Cavity/cytology , Peritoneal Cavity/parasitology , Peritoneal Cavity/pathology , Peritoneal Fibrosis/immunology , Peritoneal Fibrosis/pathology , Taenia
3.
J Helminthol ; 82(3): 211-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18394210

ABSTRACT

Mesocestoides vogae tetrathyridia infection in mice causes hepatocyte injury, hepatic granulomatous inflammmation, liver fibrosis and chronic peritonitis manifested with portal hypertension. To reduce the detrimental effect of parasites on the host liver, the effect of the anthelmintic drug praziquantel (PZQ) in combination with natural products silymarin (an antioxidant) and beta-glucan (an immunomodulator) was investigated. The therapeutic effect of drugs was assessed by means of aminotransferase (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) activities, content of albumin, total proteins and hyaluronic acid (HA) in sera of ICR mice infected with M. vogae larvae. Animals were treated with PZQ suspended in oil emulsion (Group 1), PZQ combined with silymarin incorporated into lipid microspheres (LMS) (Group 2), PZQ combined with beta-glucan incorporated into liposomes (LG) (Group 3), PZQ co-administered with LMS and LG (Group 4). Untreated animals (Group 5) served as the control. Treatment of animals started at the early chronic phase of infection (day 14 p.i.) and lasted 10 days; serum samples were collected on days 0, 7, 14, 25, 28, 31, 35 and 45 p.i. ALT and AST activities were significantly (P < 0.05) decreased in Groups 2, 3 and 4. HA content was significantly (P < 0.05 and 0.01) lower in Groups 2 and 4. Albumin levels were decreased in Groups 2 and 4, total protein concentration decreased in Groups 1 and 3 (P < 0.05 and 0.01). These results showed that combined treatment of PZQ with silymarin and/or beta-glucan was able to ameliorate or suppress fibrogenesis in the liver, protect liver cells from oxidative damage and, possibly, stimulate regeneration of the parenchyma.


Subject(s)
Cestode Infections , Hypertension, Portal/drug therapy , Liver Diseases, Parasitic/drug therapy , Liver/injuries , Mesocestoides/isolation & purification , Mice, Inbred ICR/parasitology , Alanine Transaminase/pharmacology , Animals , Anthelmintics/administration & dosage , Antioxidants/administration & dosage , Aspartate Aminotransferases/pharmacology , Drug Therapy, Combination , Immunologic Factors/administration & dosage , Liver/parasitology , Male , Mesocestoides/drug effects , Mice , Peritoneal Cavity/parasitology , Praziquantel/administration & dosage , Silymarin/administration & dosage , beta-Glucans/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL